
å»çãã¥ãŒã¹ïŒ11æ16æ¥åïŒ
ããèããã®æ°è¬ãç¡ç æç¡åŒåžã®é£²ã¿è¬ãFDAã®èºããè¬äžæ¿èªãªã©ã11æ15æ¥ã®å»çã®è©±é¡ããŸãšããŸããã
æ°è¬ãæ»æçãªããèãããæ¶æ» ããããããŠã¹ã§4åã®3ãæ¶å€±
å®éšè¬ãFEBP-sTβRIIãããæ»æçãªããèããã®ããŠã¹ã¢ãã«ã§è «çãæ¶å€±ããããããèããã¯åãçµç¹ã«å²ãŸãå ç«çްèãå±ãã«ãããããã®è¬ã¯ãã现èãå©çšããã·ã°ãã«ãTGF-βããé»å®³ããè «çãå®ãããªã¢ã匱ãããç¹ã«æ»æçãªã¢ãã«ã§ã¯æ²»çããããŠã¹ã®75ïŒ ã§è «çãæ¶å€±ãã8å¹äž7å¹ãæ²»ççµäºãã270æ¥åŸãçåããŠãããå ç«çްèãè «çå ã«å ¥ã蟌ã¿ãåã³ãããæäžããŠãå ç«ãæçµ¶ããäŸããã£ããè«æã¯ãCancer Cellãã«æ²èŒããããããçã¯åæã®å®å šæ§è©Šéšã«å ¥ã£ãŠãããèšåºè©Šéšã¯2027幎ã«èšç»ãããŠãããããã§æå¹ãšã¯ãŸã 瀺ãããŠããªãã
è³ãšå¿èã®çžäºäœçšãé žçŽ æ¬ ä¹ããã®å埩ãäºæž¬ã§ããå¯èœæ§
è³ã®é žçŽ æ¬ ä¹ïŒè³ç¡é žçŽ çïŒã¯äžçã®äž»èŠãªæ»å ã®äžã€ã§ãå埩ããŠãç¥çµåŠçãªåŸéºçãæ®ããããªè³ç ç©¶æã®ç ç©¶ããŒã ã¯ãé床ã®é žçŽ æ¬ ä¹ãèµ·ãããã©ããã®ã¢ãã«ã§ãè³ãšå¿èã®çžäºäœçšãèçåŸã®çåãäºæž¬ã§ãããã調ã¹ããæ»ã«è¿ãç¶æ ã®åŸãã©ããã®è³æŽ»åã¯å€§ããæžè¡°ããå¿æå€åã¯é«ããªã£ãŠãããç¹ã«ãäœæ§æèŠéãšæµ·éЬã«ãããè³æŽ»åãšé£åããå¿è掻åããã©ããã®çåãæ£ç¢ºã«äºæž¬ãããç ç©¶ããŒã ã¯ããã®ç¥èŠãããã§ã®ç ç©¶ãžã®éãéããæ£è ã®å埩èŠéããæž¬ãææšã«ã€ãªããããšãæåŸ ããŠãããè«æã¯ãeNeuroã2026å¹Žã«æ²èŒãããã
https://medicalxpress.com/news/2026-11-brainheart-interactions-recovery-oxygen-loss.html
ç¡ç æç¡åŒåžã®é£²ã¿è¬ãCPAPãã¹ã¯ã®ä»£æ¿ã«ãªãå¯èœæ§ãåŒåžã®äžæãæå€§47ïŒ æžå°
ãŠãããæ²»çã«äœ¿ãããŠããè¬ãã¹ã«ãã¢ã ãããé塿§ç¡ç æç¡åŒåžã®äººã®å€éã®åŒåžãå®å®ãããå¯èœæ§ãèšåºè©Šéšã§ç€ºããããã¹ãŠã§ãŒãã³ã»ãšãŒãããªå€§åŠãªã©ã®ããŒã ããæ¬§å·4ãåœã§äžççãéçã®æäºº298人ã察象ã«è©Šéšããé«çšéã§ã¯ãã©ã»ããšæ¯ã¹ãŠåŒåžã®äžæãæå€§47ïŒ æžå°ããç¡ç äžã®é žçŽ ã¬ãã«ãæ¹åãããCPAPã¯ãã¹ã¯ã§ç©ºæ°ãéãæ°éãéãããè£ çã®äžå¿«æãªã©ã§ç¶ç¶ãé£ãã人ããããã¹ã«ãã¢ã ã¯åŒåžã®å¶åŸ¡ã«åãããããšã¿ããããå¯äœçšã¯å€ãã軜床ã»äžæçãšãããããçæéã®è©Šéšã®ããé·æã®å®å šæ§ã¯äžæã ãç¡ç æç¡åŒåžã®æ²»çè¬ãšããŠã¯æªæ¿èªã§ãããå€§èŠæš¡ã§é·æã®ç ç©¶ãå¿ èŠãšããããç ç©¶ã¯ãThe Lancetãã«æ²èŒãããã
è¡æ äºé²è¬ãé¢ç¯çã®é¢ç¯ç Žå£ãé ãããå¯èœæ§ãããŠã¹ãšãµã«ã§ç¢ºèª
è¡æ äºé²ã«äœ¿ãããè¬ãããã¬ãã©ã³ãããå€åœ¢æ§é¢ç¯çã®é¢ç¯ç Žå£ãé ãããå¯èœæ§ãåæç ç©¶ã§ç€ºããããã€ã§ãŒã«å€§åŠã®ç ç©¶ããŒã ã¯æ¿èªæžã¿å»è¬å980åç®ã調ã¹ãé¢ç¯ç Žå£ã«é¢ããççãæããããªè¬ã3åç®ç¹å®ããããã¬ãã©ã³ã«çµã£ãŠæ€èšŒãããæè¡ã§å€åœ¢æ§é¢ç¯çãèµ·ãããããŠã¹ãšãã«ã¯ã¶ã«ã§ãããã¬ãã©ã³ã¯é¢ç¯ã®æå·ãæžãããåããæ¹åãããããã§æå¹ãã¯ãŸã 瀺ãããŠããããé¢ç¯çã®æ²»çç®çã§è¡æ¶²ããµã©ãµã©ã«ããè¬ãèªå·±å€æã§å§ããã倿ŽãããããŠã¯ãããªããšç ç©¶ããŒã ã¯æ³šæãä¿ããŠãããç ç©¶ã¯ãScience Translational Medicineãã«æ²èŒãããã
FDAããµããã瀟ã®èºããè¬ã€ããã·ãããäžæ¿èªãå šçåæéã§ææå·®ãªã
ç±³é£åå»è¬åå±ïŒFDAïŒã¯11æ15æ¥ããµãããã»ã»ã©ãã¥ãŒãã£ã¯ã¹ç€Ÿã®èºããè¬ã€ããã·ããã«ã€ããŠãæ¿èªãèŠéããå®å šåçæžç°¡ïŒCRLïŒããåºããã察象ã¯EGFRå€ç°ã®ãã屿é²è¡ã»è»¢ç§»æ§éå°çްèèºããã§ãEGFRæšçæ²»çãåããåŸã®æ£è ãžã®çœé補å€ååŠçæ³ãšã®äœµçšã ãæ ¹æ ãšãªã£ã第3çžè©ŠéšHARMONiã§ã¯ãç å¢é²è¡ã»æ»äº¡ãªã¹ã¯ãååŠçæ³åç¬ãã48ïŒ äœäžãç¡å¢æªçåæéã®ç®æšã¯éæããããäž»èŠè©äŸ¡é ç®ã®äžã€ã§ããå šçåæéã§çµ±èšçã«ææãªæ¹åã瀺ãããªãã£ããã€ããã·ããã¯PD-1ãšVEGFã®äž¡æ¹ãé»å®³ããäºéç¹ç°æ§æäœã§ã2024幎5æã«äžåœã§æ¿èªæžã¿ã ãç±³åœã𿬧å·ã§ã¯æªæ¿èªã ãå瀟ã¯å¥è©ŠéšHARMONi-3ã®çµæã幎å ã«å ±åããäºå®ã ã
éºäŒæ§è¡ç®¡æ§æµ®è «ã®é£²ã¿è¬ãçºäœã83ïŒ æžå°ã第3çžè©Šéšã§
1æ¥1åã®çµå£è¬ãããŠã¯ãªã¯ããã³ãXRãããéºäŒæ§è¡ç®¡æ§æµ®è «ã®æéçºäœããã©ã»ããšæ¯ã¹ãŠ83ïŒ æžããããéçºå ã®ãã¡ã«ããªã¹ç€Ÿã11æ12æ¥ã«çºè¡šãã11æ14æ¥ã«ã¢ã¬ã«ã®ãŒå°éå»ã®å¹Žæ¬¡åŠäŒã§çºè¡šãããåœéå ±å第3çžè©ŠéšCHAPTER-3ã§ã¯85人ã2察1ã®å²åã§40mgé ãŸãã¯ãã©ã»ãã«ç¡äœçºã«å²ãä»ãã24é±éæäžãããå¹æã¯æäžéå§1é±é以å ã«çŸããè©Šéšæéäžæç¶ããããã ãæªæ¿èªã®éçºåã§ã詊éšèŠæš¡ã¯85人ãšå°ãããå¯äœçšã¯è¬çŸ€ã§å€ãïŒ76.4ïŒ å¯Ÿ56.7ïŒ ïŒãèé µçŽ äžæã®é床äŸã2ä»¶ããã1ä»¶ã¯æäžäžæ¢ãšãªã£ããå瀟ã¯2027幎äžåæã®æ¿èªç³è«ãèšç»ããŠããã
åžå°é£ç ã®åå é µçŽ ã®å šäœåãåè§£æãã¯ã©ã€ãªé»é¡ã§
ããŠã³ããµã€ãã€ã®ç ç©¶ããŒã ããåžå°ãªéºäŒæ§çŸæ£ãã°ã«ã¿ã«é žå°¿ç1åïŒGA1ïŒãã®åå ãšãªãé µçŽ AASSã®å šäœåãåããŠè©³çŽ°ã«æãåºãããGA1ã¯é µçŽ ã®æ©èœäžå šã«ããäžå¯éçãªè³æå·ãåŒãèµ·ããããšããããç ç©¶ããŒã ã¯ããã®å®å šãªAASSé µçŽ ãåé¢ããã¯ã©ã€ãªé»åé¡åŸ®é¡ã§æ§é ãè§£æãçååŠå®éšãšã³ã³ãã¥ãŒã¿ãŒã·ãã¥ã¬ãŒã·ã§ã³ã§åãæ¹ã瀺ãããAASSãé»å®³ããããšãæ²»çã«ã€ãªããå¯èœæ§ã瀺åããããçŸæ®µéã¯å®éšå®€ã§ã®ç ç©¶ã«ãšã©ãŸããæ²»çæ³ãæ²»çã§ã¯ãªããå®å šæ§ãšæå¹æ§ã瀺ãåç©å®éšãããã§ã®ç ç©¶ãä»åŸå¿ èŠã ãè«æã¯11æ13æ¥ã«ãScience Advancesãã«æ²èŒãããã
ãã«ã¢ã³æ§é«è¡å§ã®æ°è¬ãæäžçµäºåŸãæé·2幎è¡å§ãäžããç¶ã
ã¢ã«ãã¹ããã³åæé µçŽ é»å®³è¬ã«ããé·ææ²»çãåãããã«ã¢ã³æ§é«è¡å§ã®æ£è ã§ãæè¬çµäºåŸãæé·2幎éããã«ã¢ã³å€ãšè¡å§ãæ²»çåããäœãç¶æ ãç¶ãããç±³åœã®8æœèšã§å®æœãããæ£è ã¯å®éšè¬ã6ã12ãææçšããçµäºåŸã®çµéã远跡ãããéå°ãªã¢ã«ãã¹ããã³ã®ææšã¯æ²»çåã®æ°Žæºãã99ïŒ äœäžãããŸãŸã ã£ããè¡å§ã¯å¹³å25ãã€ã³ãäœäžããåå è ã®çŽ4åã®1ãä»ã®è¬ãªãã§æ£åžžè¡å§ãéæãããçé èè ã®ã¢ãªã¹ã»ãã©ãŠã³æ°ã¯ãæéã®æè¬ã§ç¡éã®æ²»çã«ã€ãªããå¯èœæ§ããæ éã«ç€ºåãããç ç©¶ããŒã ã¯å¯è ã®ååã€ã¡ãŒãžã³ã°ãçšããå€§èŠæš¡ãªååã詊éšãELIXIRããéå§ããããã³ãã³å€§åŠã¯ã€ãŒã³ã»ã¡ã¢ãªãŒæ ¡ã«ããç ç©¶ã§ã11æ15æ¥ã«å ±ããããã
https://www.archynewsy.com/new-drug-may-offer-lasting-cure-for-hormonal-high-blood-pressure/
å°å äœæªæ§åºŠç¥çµè è «ã®è¬ããã©ãã§ããã4å¹Žè¿œè·¡ã§æ¬¡ã®æ²»çãŸã§äžå€®å€50.9ãæ
å°å ã®åçºæ§BRAFå€ç°äœæªæ§åºŠç¥çµè è «ã察象ãšãã第2çžè©ŠéšFIREFLY-1ã®4幎远跡ããŒã¿ã§ãããã©ãã§ããïŒè£œååãªãžã§ã ãïŒã®æäžåŸãæ¬¡ã«æ²»çãå¿ èŠã«ãªããŸã§ã®æéã®äžå€®å€ã50.9ãæã«éãã1幎åã®å ±åã®42.6ãæãã8ãæå»¶ã³ããå¯Ÿè±¡ã¯æå¹æ§è©äŸ¡ãå¯èœãª76人ã26é±éã®é±1åæäžãçµããŠä»»æã®ç¡æ²»çæéã«å ¥ã£ã41人ã®ãã¡54ïŒ ã2幎æç¹ã§ç¡æ²»çãç¶æããç¡æ²»çæéã®äžå€®å€ã¯æªå°éã ã£ããåæäžã§ã广ãä¿ãããå åããã£ããè©Šéšæéã®äžå€®å€ã¯52.5ãæãå®å šæ§ã¯137äººå šäœã§3幎æç¹ããå€ããããæé·æå¶ãžã®æžå¿µãé·æããŒã¿ã§ã¯èœã¡çããèªã¿ãšãªã£ããããŒã¿ã¯11æ14æ¥ã«ç¥çµè «çåŠäŒSNO 2026ã§çºè¡šãããã
補è¬å€§æã次äžä»£è¥æºçæ²»çè¬ã®éçºã§äžåœã«ç §æº
äžçã®å€§æè£œè¬äŒç€Ÿã次äžä»£ã®è¥æºçæ²»çè¬ãæ±ããŠäžåœã«ç®ãåããŠãããäž»åè¬ã®ç¹èš±åããè¿«ãäžãããã»ãã«ãã£ã¹ã¯ãã¢ã¹ãã©ãŒãã«ããã¡ã€ã¶ãŒãªã©ãæ°ããªéçºã®çš®ãæ¢ããŠãããäžåœã§ã¯ãã€ãªå»è¬åç£æ¥ãæ¥æé·ããæäŸ¡ç·é¡460åãã«ã®æ±èæçå»è¬ãã嵿¥5å¹Žã®æ°èäŒæ¥ãŸã§ãè¥æºçè¬åžå Žãç®æããäžçä¿å¥æ©é¢ïŒWHOïŒã«ãããšãäžåœã§ç»é²ãããèšåºè©Šéšã®ä»¶æ°ã¯2024幎ãŸã§ã«ç±³åœãäžåããäžåœã®ç ç©¶è ãé²ãã驿°çãªå»è¬ååè£ã¯æšå¹Žæ«æç¹ã§çŽ5,000åç®ã«éãããããã¯9æãæ±èæçå»è¬ã®çµå£è¬ã«ã€ããŠæå€§26åãã«ã§äžåœåœå€ã®éçºã»è²©å£²æš©ãååŸããããšã§åæããããã ã©ã®äºæž¬ã§ã¯è¥æºçæ²»çè¬åžå Žã¯çŸåšã®çŽ720åãã«ãã10幎ã§1,800åãã«ã«æ¡å€§ããèŠéãã ã
https://www.reuters.com/jp/opinion/breakingviews/24RBKPS5ABNU7NDV7IDOQVXPYI-2026-11-15/